Aberrant lung structure, composition, and function in a murine model of Hermansky-Pudlak syndrome

被引:68
作者
Lyerla, TA
Rusiniak, ME
Borchers, M
Jahreis, G
Tan, J
Ohtake, P
Novak, EK
Swank, RT [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA
[2] Clark Univ, Dept Biol, Worcester, MA 01610 USA
[3] SUNY Buffalo, Dept Rehabil Sci, Buffalo, NY 14214 USA
[4] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Div Toxicol, Cincinnati, OH 45267 USA
关键词
inherited lung dysfunction; inflammation; surfactant protein; lamellar body; secretion;
D O I
10.1152/ajplung.00024.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Hermansky-Pudlak syndrome (HPS) is a genetically heterogeneous inherited disease causing hypopigmentation and prolonged bleeding times. An additional serious clinical problem of HPS is the development of lung pathology, which may lead to severe lung disease and premature death. No cure for the disease exists, and previously, no animal model for the HPS lung abnormalities has been reported. A mouse model of HPS, which is homozygously recessive for both the Hps1 ( pale ear) and Hps2 ( pearl) genes, exhibits striking abnormalities of lung type II cells. Type II cells and lamellar bodies of this mutant are greatly enlarged, and the lamellar bodies are engorged with surfactant. Mutant lungs accumulate excessive autofluorescent pigment. The air spaces of mutant lungs contain age-related elevations of inflammatory cells and foamy macrophages. In vivo measurement of lung hysteresivity demonstrated aberrant lung function in mutant mice. All these features are similar to the lung pathology described in HPS patients. Morphometry of mutant lungs indicates a significant emphysema. These mutant mice provide a model to further investigate the lung pathology and therapy of HPS. We hypothesize that abnormal type II cell lamellar body structure/ function may predict future lung pathology in HPS.
引用
收藏
页码:L643 / L653
页数:11
相关论文
共 60 条
[1]   Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular characteristics [J].
Anderson, PD ;
Huizing, M ;
Claassen, DA ;
White, J ;
Gahl, WA .
HUMAN GENETICS, 2003, 113 (01) :10-17
[2]   Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico [J].
Anikster, Y ;
Huizing, M ;
White, J ;
Shevchenko, YO ;
Fitzpatrick, DL ;
Touchman, JW ;
Compton, JG ;
Bale, SJ ;
Swank, RT ;
Gahl, WA ;
Toro, JR .
NATURE GENETICS, 2001, 28 (04) :376-380
[3]  
[Anonymous], LUNG SCI FDN
[4]   Hermansky-Pudlak syndrome: Radiography and CT of the chest compared with pulmonary function tests and genetic studies [J].
Avila, NA ;
Brantly, M ;
Premkumar, A ;
Huizing, M ;
Dwyer, A ;
Gahl, WA .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (04) :887-892
[5]   New concepts in chronic obstructive pulmonary disease [J].
Barnes, PJ .
ANNUAL REVIEW OF MEDICINE, 2003, 54 :113-129
[6]   Functional redundancy of Rab27 proteins and the pathogenesis of Griscelli syndrome [J].
Barral, DC ;
Ramalho, JS ;
Anders, R ;
Hume, AN ;
Knapton, HJ ;
Tolmachova, T ;
Collinson, LM ;
Goulding, D ;
Authi, KS ;
Seabra, MC .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (02) :247-257
[7]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[8]   DEFECTIVE LYSOSOMAL ENZYME-SECRETION IN KIDNEYS OF CHEDIAK-HIGASHI (BEIGE) MICE [J].
BRANDT, EJ ;
ELLIOTT, RW ;
SWANK, RT .
JOURNAL OF CELL BIOLOGY, 1975, 67 (03) :774-788
[9]   Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1 [J].
Brantly, M ;
Avila, NA ;
Shotelersuk, V ;
Lucero, C ;
Huizing, M ;
Gahl, WA .
CHEST, 2000, 117 (01) :129-136
[10]   ABNORMAL LAMELLAR BODIES IN TYPE-2 PNEUMOCYTES AND INCREASED LUNG SURFACE-ACTIVE MATERIAL IN BEIGE MOUSE [J].
CHI, EY ;
PRUEITT, JL ;
LAGUNOFF, D .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1975, 23 (11) :863-866